In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Diana Luísa Almeida-NunesAssociate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0003-4270-7701 Ana Mendes-FriasLife and Health Sciences Research Institute (ICVS), School of Medicine from University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-7561-5347 Mariana NunesDifferentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-4733-5778 Verónica FerreiraDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Cláudia LoboDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Paula MonteiroDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.ORCID 0000-0002-3482-2307 Miguel Henriques AbreuDepartment of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Carla BartoschDepartment of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.
Claudia NobregaLife and Health Sciences Research Institute (ICVS), School of Medicine from University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-0282-9619 Ricardo Jorge Dinis-OliveiraAssociate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0001-7430-6297 Ricardo SilvestreLife and Health Sciences Research Institute (ICVS), School of Medicine from University of Minho, 4710-057 Braga, Portugal.
Sara RicardoAssociate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0003-4091-2226 Funding
Cooperativa de Ensino Superior Politécnico e Universitário ImmunoT4OC_GI2- CESPU-2023Cooperativa de Ensino Superior Politécnico e Universitário upPTXo-vcar-GI2-CESPU-2022Fundação para a Ciência e Tecnologia 2020.04720.BD-DOI: 10.54499/2020.04720.BDFundação para a Ciência e Tecnologia 2021.05081.BD-DOI: 10.54499/2021.05081.BDFundação para a Ciência e Tecnologia 2021.07836.BD-DOI: 10.54499/2021.07836.BDFundação para a Ciência e Tecnologia contract10.54499/2020.00185.CEECIND/CP1600/CT0004Fundação para a Ciência e Tecnologia LA/P/0050/2020 (DOI 10.54499/LA/P/0050/2020)Fundação para a Ciência e Tecnologia UIDB/50026/2020 (DOI 10.54499/UIDB/50026/2020)
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anti-PD-1high-grade serous carcinomamalignant ascitic fluidT cell exhaustion-like phenotypetumor immune microenvironment
Identifiers
PMID42649924
PMCPMC13511107
What OpenQuestion holds
Textmetadata
Read underepoch 390